Meeting
2020 Gastrointestinal Cancers Symposium
Evaluation of the current treatment strategies for pancreatic neuroendocrine tumors.
Authors
Kenneth Lee Meredith
Florida State University College of Medicine/Sarasota Memorial Hospital, Sarasota, FL
Kenneth Lee Meredith , Taylor Maramara , Paige Blinn , Jamie Huston , Ravi Shridhar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 611)
Abstract #
611
Poster Bd #
F14
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Incidence and survival patterns of pancreatic neuroendocrine tumors over the last two decades: A SEER database analysis.
First Author: Mohamad Bassam Sonbol
Poster
2018 Gastrointestinal Cancers Symposium
Survival for small, well-differentiated PNETs in relation to treatment.
First Author: bao-Quynh Julian
Poster
2017 Gastrointestinal Cancers Symposium
Predictive factors for long-term survival after conversion surgery for unresectable gastric cancer: A retrospective analysis.
First Author: Tamotsu Sagawa
Poster
2015 ASCO Annual Meeting
Estrogen receptor beta (ERβ) gene polymorphisms as a predictor of overall survival in patients with gastric cancer (GC) from Japan and Los Angeles County (LAC).
First Author: Anish Parekh